{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:19:05Z","timestamp":1792423145404,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jsat.2022.108832","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T01:41:20Z","timestamp":1656294080000},"page":"108832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Adapting methadone inductions to the fentanyl era"],"prefix":"10.1016","volume":"141","author":[{"given":"Megan","family":"Buresh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe M.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2022.108832_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.01.004","article-title":"Characterizing fentanyl use in methadone-maintained clients","volume":"75","author":"Arfken","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.jsat.2022.108832_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.ADM.0000435321.39251.d7","article-title":"Safe methadone induction and stabilization report of an expert panel","volume":"7","author":"Baxter","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2022.108832_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/ajad.12711","article-title":"Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies","volume":"27","author":"Bisaga","year":"2018","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2022.108832_bb0020","series-title":"Risk Mitigation in the Context of Dual Health Emergencies\u2014Interim Clinical Guidance: Update","year":"2022"},{"key":"10.1016\/j.jsat.2022.108832_bb0025","author":"Bromley"},{"issue":"8","key":"10.1016\/j.jsat.2022.108832_bb5000","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","article-title":"An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam","volume":"97","author":"Buster","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2022.108832_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.jsat.2022.108832_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.12.009","article-title":"J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study","volume":"173","author":"Cousins","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"14","key":"10.1016\/j.jsat.2022.108832_bb0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.jsat.2022.108832_bb0045","series-title":"Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule","first-page":"4085","volume":"66(11)","year":"2001"},{"key":"10.1016\/j.jsat.2022.108832_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.jsat.2022.108832_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/ADM.0000000000000507","article-title":"Initiation and rapid titration of methadone in an acute care setting for the treatment of opioid use disorder: A case report","volume":"13","author":"Hemmons","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2022.108832_bb0060","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/add.14188","article-title":"The impact of buprenorphine and methadone on mortality: A primary care cohort study in the United Kingdom","volume":"113","author":"Hickman","year":"2018","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2022.108832_bb0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/10826084.2016.1246571","article-title":"High concomitant misuse of fentanyl in subjects on opioid maintenance treatment","volume":"52","author":"Krause","year":"2017","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2022.108832_bb0070","author":"Leavitt"},{"issue":"9","key":"10.1016\/j.jsat.2022.108832_bb0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2022.108832_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108031","article-title":"One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission","volume":"115","author":"Stone","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108832_bb0085","series-title":"Medications for Opioid Use Disorder Treatment Improvement Protocol (TIP) Series 63","year":"2021"},{"issue":"2","key":"10.1016\/j.jsat.2022.108832_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20846","article-title":"The epidemic of fentanyl misuse and overdoses: challenges and strategies","volume":"20","author":"Volkow","year":"2021","journal-title":"World Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:56:20Z","timestamp":1760039780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":19,"alternative-id":["S0740547222001143"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108832","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adapting methadone inductions to the fentanyl era","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108832"}}